Note 11 - Stockholders' Equity (Details Textual) - USD ($) |
6 Months Ended | |
|---|---|---|
Jan. 07, 2025 |
Jun. 30, 2025 |
|
| Chemular Warrants [Member] | ||
| Class of Warrant or Right, Issued During Period | 3,700,000 | 3,700,000 |
| Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 0.1 | |
| Warrants and Rights Outstanding | $ 148,000 | |
| Conversion of Series A Preferred Stock to Common Stock [Member] | ||
| Conversion of Stock, Shares Issued | 127,000 | |
| Conversion of Stock, Shares Converted | 564 |
| X | ||||||||||
- Definition The amount of warrants or rights issued during the period. No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|